5591-29-7 Usage
Uses
Used in Pharmaceutical Industry:
Etafedrine hydrochloride is used as a bronchodilator for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its selective action on β-adrenergic receptors helps to relax the smooth muscles surrounding the bronchial tubes, leading to improved airflow and reduced symptoms.
Used in Pulmonary Medicine:
In the field of pulmonary medicine, etafedrine hydrochloride is utilized as a therapeutic agent to alleviate symptoms associated with respiratory disorders. Its long-acting properties make it an effective choice for managing conditions that require continuous bronchodilation, such as exercise-induced bronchoconstriction.
Used in Emergency Medicine:
Etafedrine hydrochloride is also used in emergency medicine as a supportive treatment for patients experiencing severe respiratory distress. Its rapid onset and long-lasting effects make it a suitable option for providing immediate relief and maintaining bronchodilation during critical situations.
Overall, etafedrine hydrochloride is a versatile and effective compound in the management of respiratory conditions, offering both immediate and long-term benefits to patients in need of bronchodilation.
Check Digit Verification of cas no
The CAS Registry Mumber 5591-29-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,9 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5591-29:
(6*5)+(5*5)+(4*9)+(3*1)+(2*2)+(1*9)=107
107 % 10 = 7
So 5591-29-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H19NO.ClH/c1-4-13(3)10(2)12(14)11-8-6-5-7-9-11;/h5-10,12,14H,4H2,1-3H3;1H
5591-29-7Relevant academic research and scientific papers
The synthesis of new bronchodilator prodrugs
Adams, Mortimer H.,Ameer, Farouk,Green, Ivan R.,Syce, James A.
, p. 2419 - 2430 (2007/10/03)
Prodrug 14 has been synthesized to investigate its lung accumulating property while prodrugs 19, 20 and 22 incorporating structural features of 14 have been prepared for evaluation as bronchodilatory agents.
